COMBINED EFFECT OF OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO OR INTOLERANCE OF URSODEOXYCHOLIC ACID: RESULTS FROM TWO PHASE 2 CLINICAL TRIALS

被引:0
|
作者
Levy, Cynthia [1 ]
Hejda, Vaclav [2 ]
Louvet, Alexandre [3 ]
Younes, Ziad [4 ]
Mendizabal, Manuel [5 ]
Bonder, Alan [6 ]
Zou, Heng [7 ]
Civitarese, Antonio [7 ]
Villamil, Alejandra [8 ]
Nevens, Frederik [9 ]
机构
[1] Univ Miami, Sch Med, Coral Gables, FL 33124 USA
[2] Univ Hosp Plzen, Plzen, Czech Republic
[3] Univ Hosp Lille, Lille, France
[4] Gastro One, Germantown, TN USA
[5] Hosp Univ Austral, Pilar, Argentina
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[7] Intercept Pharmaceut Inc, Morristown, NJ USA
[8] Hosp Italiano Buenos Aires, Hepat Autoimmun Unit, Buenos Aires, DF, Argentina
[9] Univ Hosp KU Leuven, Leuven, Belgium
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
5019-C
引用
收藏
页码:E52 / E52
页数:1
相关论文
共 50 条
  • [31] Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry
    Diaz Gonzalez, Alvaro
    Gonzalez Pascual, Andrea
    Gomez-Camarero, Judith
    Gomez Dominguez, Elena
    Carlota Londono, Maria
    Vergara Gomez, Mercedes
    Ampuero, Javier
    Martinez, Javier
    Horta, Diana
    Gallego, Adolgo
    Salmeron, Javier
    Garcia-Retortillo, Montserrat
    Morillas, Rosa M.
    Andrade, Raul J.
    Turnes, Juan
    Diago, Moises
    El Hajra Martinez, Ismael
    Roget Alemany, Merce
    Hernandez Guerra, Manuel
    Quintans, Nerea
    Sala, Margarita
    Dominguez, Nuria
    Arencibia Almeida, Ana
    Crespo, Javier
    Barreira, Ana
    Salcedo, Magdalena
    Riveiro Barciela, Mar
    JOURNAL OF HEPATOLOGY, 2023, 78 : S376 - S377
  • [32] Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis
    Tanaka, Atsushi
    Hirohara, Junko
    Nakano, Toshiaki
    Yagi, Minami
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    Nakanuma, Yasuni
    Takikawa, Hajime
    HEPATOLOGY RESEARCH, 2018, 48 (09) : 727 - 734
  • [33] Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid
    Lens, Sabela
    Leoz, Maria
    Nazal, Leyla
    Bruguera, Miguel
    Pares, Albert
    LIVER INTERNATIONAL, 2014, 34 (02) : 197 - 203
  • [34] EFFECT OF FIBRATE-ADD-ON TREATMENT IN PRIMARY BILIARY CHOLANGITIS PATIENTS WITH AN INSUFFICIENT RESPONSE TO URSODEOXYCHOLIC ACID
    Freissmuth, C.
    Kozbial, K.
    Staettermayer, A. F.
    Beinhardt, S.
    Stern, R.
    Halilbasic, E.
    Ferenci, P.
    Trauner, M.
    Hofer, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S434 - S435
  • [35] Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features
    Wen, Maoyao
    Men, Ruoting
    Fan, Xiaoli
    Shen, Yi
    Ni, Ping
    Hu, Zhichao
    Yang, Li
    DIGESTIVE DISEASES, 2021, 39 (04) : 366 - 374
  • [36] ECONOMIC IMPACT OF NON-RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS PATIENTS
    Sharma, Parivrudh
    Crighton, Lynne
    Vijayan, Balasubramaniam
    English, Shirley
    Mukhopadhya, Ashis
    GUT, 2019, 68 : A129 - A130
  • [37] Analysis of predictive response scores to treatment with ursodeoxycholic acid in patients with primary biliary cholangitis
    Brunet, Eduard
    Hernandez, Leticia
    Miquel, Mireia
    Sanchez-Delgado, Jordi
    Dalmau, Blai
    Valero, Oliver
    Vergara, Mercedes
    Casas, Meritxell
    MEDICINA CLINICA, 2019, 152 (10): : 377 - 383
  • [38] EARLY IDENTIFICATION OF INSUFFICIENT BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Perez, Carla Fiorella Murillo
    Ioannou, Stephanie
    Hassanally, Iman
    Trivedi, Palak
    Corpechot, Christophe
    Van der Meer, Adriaan J.
    Lammers, Willem J.
    Battezzati, Pier Maria
    Lindor, Keith D.
    Nevens, Frederik
    Kowdley, Kris
    Bruns, Tony
    Cazzagon, Nora
    Floreani, Annarosa
    Mason, Andrew L.
    Gulamhusein, Aliya F.
    Ponsioen, Cyriel
    Carbone, Marco
    Lleo, Ana
    Mayo, Marlyn J.
    Dalekos, George
    Gatselis, Nikolaos K.
    Thorburn, Douglas
    Verhelst, Xavier
    Pares, Albert
    Janssen, Harry L. A.
    Invernizzi, Pietro
    Vuppalanchi, Raj
    Hirschfield, Gideon
    Hansen, Bettina E.
    Levy, Cynthia
    HEPATOLOGY, 2021, 74 : 759A - 760A
  • [39] A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis
    Yagi, Minami
    Matsumoto, Kosuke
    Komori, Atsumasa
    Abe, Masanori
    Hashimoto, Naoaki
    Inao, Mie
    Namisaki, Tadashi
    Kawata, Kazuhito
    Ninomiya, Masashi
    Fujii, Hideki
    Takahashi, Atsushi
    Kang, Jong-Hon
    Takamura, Masaaki
    Arakawa, Mie
    Joshita, Satoru
    Sato, Ken
    Itakura, Jun
    Nomura, Takako
    Kakisaka, Keisuke
    Kaneko, Akira
    Tamura, Yamato
    Miura, Ryo
    Aiso, Mitsuhiko
    Arizumi, Toshihiko
    Asaoka, Yoshinari
    Kikuchi, Kentaro
    Takikawa, Yasuhiro
    Masaki, Tsutomu
    Umemura, Takeji
    Honda, Akira
    Ohira, Hiromasa
    Kawada, Norifumi
    Yoshiji, Hitoshi
    Mochida, Satoshi
    Takikawa, Hajime
    Tanaka, Atsushi
    LIVER INTERNATIONAL, 2020, 40 (08) : 1926 - 1933
  • [40] Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection
    Bowlus, Christopher L.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 89 - 95